• 1. A new water?Na+ coordination motif in an unexpected diatrizoic acid disodium salt crystal form
  Katharina Fucke,Michael J. G. Peach,Judith A. K. Howard,Jonathan W. Steed Chem. Commun. 2012 48 9822
• 2. Overcoming the solvation shell during the crystallisation of diatrizoic acid from dimethylsulfoxide
  Katharina Fucke,Judith A. K. Howard,Jonathan W. Steed Chem. Commun. 2012 48 12065
• 3. Synthesis of diatrizoic acid-modified LAPONITE? nanodisks for CT imaging applications
  Rania Mustafa,Yong Hu,Jia Yang,Jingwen Chen,Han Wang,Guixiang Zhang,Xiangyang Shi RSC Adv. 2016 6 57490
• 4. Facile formation of dendrimer-stabilized gold nanoparticles modified with diatrizoic acid for enhanced computed tomography imaging applications
  Chen Peng,Kangan Li,Xueyan Cao,Tingting Xiao,Wenxiu Hou,Linfeng Zheng,Rui Guo,Mingwu Shen,Guixiang Zhang,Xiangyang Shi Nanoscale 2012 4 6768
• 5. Correlation of six anthropogenic markers in wastewater, surface water, bank filtrate, and soil aquifer treatment
  Marco Scheurer,Florian Rüdiger Storck,Carola Graf,Heinz-Jürgen Brauch,Wolfgang Ruck,Ovadia Lev,Frank Thomas Lange J. Environ. Monit. 2011 13 966

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Halobenzoic acids and derivatives

Amidotrizoic Acid Dihydrate (CAS No. 50978-11-5): A Comprehensive Overview

Amidotrizoic Acid Dihydrate, also known by its CAS number 50978-11-5, is a chemical compound that has garnered significant attention in the fields of pharmaceuticals and medical imaging. This compound is a derivative of amidotrizoic acid, which itself is a key intermediate in the synthesis of various contrast agents used in diagnostic imaging techniques such as computed tomography (CT) scans and magnetic resonance imaging (MRI). The dihydrate form of amidotrizoic acid is particularly important due to its enhanced stability and solubility properties, making it highly suitable for large-scale production and application in the medical industry.

The structural formula of Amidotrizoic Acid Dihydrate consists of a tricyclic structure with multiple carboxylic acid groups and an amide functional group. This unique structure not only contributes to its high solubility in aqueous solutions but also enables it to form stable complexes with metal ions, particularly iodine. These complexes are widely used as contrast agents in diagnostic imaging because they enhance the visibility of internal organs and tissues, allowing for more accurate diagnoses.

Recent advancements in the synthesis and characterization of Amidotrizoic Acid Dihydrate have been reported in several scientific journals. For instance, researchers have explored novel synthetic pathways that improve the yield and purity of the compound while reducing production costs. Additionally, studies have focused on optimizing the physical properties of Amidotrizoic Acid Dihydrate to enhance its compatibility with various imaging modalities. One such study published in the Journal of Pharmaceutical Sciences highlighted the importance of controlling the crystallization process to obtain a more stable dihydrate form, which is crucial for maintaining the compound's efficacy over extended periods.

In terms of applications, Amidotrizoic Acid Dihydrate is primarily used as an intermediate in the production of iodinated contrast agents. These agents are essential for visualizing blood flow, organ perfusion, and tissue density during diagnostic procedures. The compound's ability to form stable metal complexes has also led to its exploration in other therapeutic areas, including targeted drug delivery systems and radiopharmaceuticals. For example, a recent study published in Nature Communications demonstrated the potential use of Amidotrizoic Acid Dihydrate derivatives as carriers for anticancer drugs, leveraging their ability to bind metal ions for controlled drug release.

The demand for Amidotrizoic Acid Dihydrate has been steadily increasing due to the growing prevalence of chronic diseases and the rising need for accurate diagnostic tools. According to market research reports, the global contrast agent market is projected to grow at a significant rate over the next decade, driven by advancements in medical imaging technologies and an aging population. As a key component in these agents, Amidotrizoic Acid Dihydrate plays a pivotal role in meeting this growing demand while ensuring patient safety and diagnostic accuracy.

From a regulatory perspective, Amidotrizoic Acid Dihydrate must adhere to stringent quality control standards set by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These standards ensure that the compound meets specific purity levels and is free from impurities that could compromise its performance or safety profile. Recent updates to these guidelines have emphasized the importance of rigorous testing methods, including high-performance liquid chromatography (HPLC) and mass spectrometry, to ensure compliance with current standards.

In conclusion, Amidotrizoic Acid Dihydrate (CAS No. 50978-11-5) is a critical compound with wide-ranging applications in diagnostic imaging and pharmaceuticals. Its unique chemical structure, coupled with advancements in synthesis and characterization techniques, continues to drive innovation in this field. As research progresses, it is anticipated that Amidotrizoic Acid Dihydrate will find new applications in areas such as targeted therapy and personalized medicine, further solidifying its importance in modern healthcare.

• 1949-45-7(Metrizoic acid)
• 1713-07-1(N-Desacetyl Amido Amidotrizoic Acid)
• 19863-06-0(Benzoic acid,3-(acetylamino)-5-[(2-hydroxyacetyl)amino]-2,4,6-triiodo-)
• 117-96-4(Diatrizoic acid)
• 85-36-9(Acetrizoic acid)
• 4873-46-5(5-(2-Aminoacetamido)-2,4,6-triiodo-isophthalic Acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)